793 related articles for article (PubMed ID: 25488896)
1. Treatment of IBD: where we are and where we are going.
Bernstein CN
Am J Gastroenterol; 2015 Jan; 110(1):114-26. PubMed ID: 25488896
[TBL] [Abstract][Full Text] [Related]
2. Medical Therapy for Inflammatory Bowel Disease.
Grevenitis P; Thomas A; Lodhia N
Surg Clin North Am; 2015 Dec; 95(6):1159-82, vi. PubMed ID: 26596920
[TBL] [Abstract][Full Text] [Related]
3. From airway inflammation to inflammatory bowel disease: eotaxin-1, a key regulator of intestinal inflammation.
Adar T; Shteingart S; Ben Ya'acov A; Bar-Gil Shitrit A; Goldin E
Clin Immunol; 2014 Jul; 153(1):199-208. PubMed ID: 24786916
[TBL] [Abstract][Full Text] [Related]
4. Will novel oral formulations change the management of inflammatory bowel disease?
Nielsen OH; Seidelin JB; Ainsworth M; Coskun M
Expert Opin Investig Drugs; 2016 Jun; 25(6):709-18. PubMed ID: 26967267
[TBL] [Abstract][Full Text] [Related]
5. Use of biologic agents in pediatric inflammatory bowel disease.
Rosh JR
Curr Opin Pediatr; 2009 Oct; 21(5):646-50. PubMed ID: 19629010
[TBL] [Abstract][Full Text] [Related]
6. The intestinal anti-inflammatory effect of minocycline in experimental colitis involves both its immunomodulatory and antimicrobial properties.
Garrido-Mesa N; Camuesco D; Arribas B; Comalada M; Bailón E; Cueto-Sola M; Utrilla P; Nieto A; Zarzuelo A; Rodríguez-Cabezas ME; Gálvez J
Pharmacol Res; 2011 Apr; 63(4):308-19. PubMed ID: 21193045
[TBL] [Abstract][Full Text] [Related]
7. Nutraceuticals in rodent models as potential treatments for human Inflammatory Bowel Disease.
Ghattamaneni NKR; Panchal SK; Brown L
Pharmacol Res; 2018 Jun; 132():99-107. PubMed ID: 29680446
[TBL] [Abstract][Full Text] [Related]
8. Optimizing conventional therapies for inflammatory bowel disease.
Sparrow MP; Irving PM; Hanauer SB
Curr Gastroenterol Rep; 2009 Dec; 11(6):496-503. PubMed ID: 19903426
[TBL] [Abstract][Full Text] [Related]
9. Vitamin D as a novel therapy in inflammatory bowel disease: new hope or false dawn?
O'Sullivan M
Proc Nutr Soc; 2015 Feb; 74(1):5-12. PubMed ID: 25490986
[TBL] [Abstract][Full Text] [Related]
10. Advances in the use of biologics and other novel drugs for managing inflammatory bowel disease.
Park SH; Aniwan S; Loftus EV
Curr Opin Pharmacol; 2017 Dec; 37():65-71. PubMed ID: 28992449
[TBL] [Abstract][Full Text] [Related]
11. The role and advances of immunomodulator therapy for inflammatory bowel disease.
Nielsen OH; Coskun M; Steenholdt C; Rogler G
Expert Rev Gastroenterol Hepatol; 2015 Feb; 9(2):177-89. PubMed ID: 25101818
[TBL] [Abstract][Full Text] [Related]
12. Inflammatory bowel disease therapy: an update.
Shah SA; Peppercorn MA
Compr Ther; 1995 Jun; 21(6):296-302. PubMed ID: 7664541
[TBL] [Abstract][Full Text] [Related]
13. Hydradenitis suppurativa and inflammatory bowel disease: An unusual, but existing association.
Principi M; Cassano N; Contaldo A; Iannone A; Losurdo G; Barone M; Mastrolonardo M; Vena GA; Ierardi E; Di Leo A
World J Gastroenterol; 2016 May; 22(20):4802-11. PubMed ID: 27239107
[TBL] [Abstract][Full Text] [Related]
14. [The immunomodulatory and anti-inflammatory properties of different antimicrobial agents].
Guz K; Bugla-Płoskońska G
Postepy Hig Med Dosw (Online); 2007 Dec; 61():828-37. PubMed ID: 18097341
[TBL] [Abstract][Full Text] [Related]
15. Drug therapy for inflammatory bowel disease in pregnancy and the puerperium.
Moffatt DC; Bernstein CN
Best Pract Res Clin Gastroenterol; 2007; 21(5):835-47. PubMed ID: 17889811
[TBL] [Abstract][Full Text] [Related]
16. Adalimumab for the treatment of inflammatory bowel disease.
Wasan SK; Kane SV
Expert Rev Gastroenterol Hepatol; 2011 Dec; 5(6):679-84. PubMed ID: 22017695
[TBL] [Abstract][Full Text] [Related]
17. Management consensus of inflammatory bowel disease for the Asia-Pacific region.
Ouyang Q; Tandon R; Goh KL; Pan GZ; Fock KM; Fiocchi C; Lam SK; Xiao SD
J Gastroenterol Hepatol; 2006 Dec; 21(12):1772-82. PubMed ID: 17074013
[TBL] [Abstract][Full Text] [Related]
18. Management of inflammatory bowel disease with infliximab and other anti-tumor necrosis factor alpha therapies.
Magro F; Portela F
BioDrugs; 2010 Dec; 24 Suppl 1():3-14. PubMed ID: 21175228
[TBL] [Abstract][Full Text] [Related]
19. Advances in inflammatory bowel diseases in children.
Michail S; Ramsy M; Soliman E
Minerva Pediatr; 2012 Jun; 64(3):257-70. PubMed ID: 22555319
[TBL] [Abstract][Full Text] [Related]
20. Immunopathogenesis of inflammatory bowel diseases: functional role of T cells and T cell homing.
Zundler S; Neurath MF
Clin Exp Rheumatol; 2015; 33(4 Suppl 92):S19-28. PubMed ID: 26458165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
